FDA Issues Final Guidance On Drug Names In Ads
The U.S. Food and Drug Administration on Monday released final guidance laying out its recommendations for how product names are displayed on advertising and promotional labeling for prescription drugs, and proposed...To view the full article, register now.
Already a subscriber? Click here to view full article